Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $22.18 million. The enterprise value is -$28.35 million.
| Market Cap | 22.18M |
| Enterprise Value | -28.35M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 8.31 million shares outstanding. The number of shares has increased by 55.85% in one year.
| Shares Outstanding | 8.31M |
| Shares Change (YoY) | +55.85% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 19.00% |
| Owned by Institutions (%) | 8.93% |
| Float | 6.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.46 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.18, with zero debt.
| Current Ratio | 8.18 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -37.90% and return on invested capital (ROIC) is -53.39%.
| Return on Equity (ROE) | -37.90% |
| Return on Assets (ROA) | -34.50% |
| Return on Capital (ROIC) | -53.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$833,600 |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.58% in the last 52 weeks. The beta is 1.07, so LSTA's price volatility has been similar to the market average.
| Beta (1Y) | 1.07 |
| 52-Week Price Change | -19.58% |
| 50-Day Moving Average | 3.02 |
| 200-Day Moving Average | 2.70 |
| Relative Strength Index (RSI) | 36.13 |
| Average Volume (30 Days) | 13,343 |
Short Selling Information
The latest short interest is 16,811, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 16,811 |
| Short Previous Month | 9,905 |
| Short % of Shares Out | 0.20% |
| Short % of Float | 0.25% |
| Short Ratio (days to cover) | 0.84 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.71M |
| Pretax Income | -23.17M |
| Net Income | -20.84M |
| EBITDA | -22.98M |
| EBIT | -23.17M |
| Earnings Per Share (EPS) | -$2.58 |
Balance Sheet
The company has $50.54 million in cash and no debt, giving a net cash position of $50.54 million or $6.08 per share.
| Cash & Cash Equivalents | 50.54M |
| Total Debt | n/a |
| Net Cash | 50.54M |
| Net Cash Per Share | $6.08 |
| Equity / Book Value | 48.15M |
| Book Value Per Share | 5.80 |
| Working Capital | 47.33M |
Cash Flow
| Operating Cash Flow | -20.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | -20.03M |
| FCF Per Share | -$2.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LSTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -55.85% |
| Shareholder Yield | -55.85% |
| Earnings Yield | -93.95% |
| FCF Yield | -90.31% |
Analyst Forecast
The average price target for LSTA is $15.00, which is 461.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 461.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -6.17% |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |